That's possible but unproven. The current thinking is that new variants are mostly likely to evolve in immunocompromised patients who experience persistent infections. Vaccines are less effective in such patients because the immune system doesn't respond as it should.

https://www.scientificamerican.com/article/covid-variants-ma...